Antibiotic associated diarrhea in outpatient pediatric antibiotic therapy
dc.contributor.author | Tanır Basaranoğlu S. | |
dc.contributor.author | Karaaslan A. | |
dc.contributor.author | Salı E. | |
dc.contributor.author | Çiftçi E. | |
dc.contributor.author | Gayretli Aydın Z.G. | |
dc.contributor.author | Aldemir Kocabaş B. | |
dc.contributor.author | Kaya C. | |
dc.contributor.author | Şen Bayturan S. | |
dc.contributor.author | Kara S.S. | |
dc.contributor.author | Yılmaz Çiftdoğan D. | |
dc.contributor.author | Çay Ü. | |
dc.contributor.author | Gundogdu Aktürk H. | |
dc.contributor.author | Çelik M. | |
dc.contributor.author | Ozdemir H. | |
dc.contributor.author | Somer A. | |
dc.contributor.author | Diri T. | |
dc.contributor.author | Yazar A.S. | |
dc.contributor.author | Sütçü M. | |
dc.contributor.author | Tezer H. | |
dc.contributor.author | Karadag Oncel E. | |
dc.contributor.author | Kara M. | |
dc.contributor.author | Çelebi S. | |
dc.contributor.author | Özkaya Parlakay A. | |
dc.contributor.author | Karakaşlılar S. | |
dc.contributor.author | Arısoy E.S. | |
dc.contributor.author | Tanır G. | |
dc.contributor.author | Tural Kara T. | |
dc.contributor.author | Devrim İ. | |
dc.contributor.author | Erat T. | |
dc.contributor.author | Aykaç K. | |
dc.contributor.author | Kaba Ö. | |
dc.contributor.author | Güven Ş. | |
dc.contributor.author | Yeşil E. | |
dc.contributor.author | Tekin Yılmaz A. | |
dc.contributor.author | Yaşar Durmuş S. | |
dc.contributor.author | Çağlar İ. | |
dc.contributor.author | Günay F. | |
dc.contributor.author | Özen M. | |
dc.contributor.author | Dinleyici E.Ç. | |
dc.contributor.author | Kara A. | |
dc.date.accessioned | 2024-07-22T08:02:04Z | |
dc.date.available | 2024-07-22T08:02:04Z | |
dc.date.issued | 2023 | |
dc.description.abstract | Background: Antibiotic-associated diarrhea is one of the most frequent side effects of antimicrobial therapy. We assessed the epidemiological data of antibiotic-associated diarrhea in pediatric patients in our region. Methods: The prospective multi-center study included pediatric patients who were initiated an oral antibiotic course in outpatient clinics and followed in a well-established surveillance system. This follow-up system constituded inclusion of patient by the primary physician, supply of family follow-up charts to the family, passing the demographics and clinical information of patient to the Primary Investigator Centre, and a close telephone follow-up of patients for a period of eight weeks by the Primary Investigator Centre. Results: A result of 758 cases were recruited in the analysis which had a frequency of 10.4% antibiotic-associated diarrhea. Among the cases treated with amoxicillin-clavulanate 10.4%, and cephalosporins 14.4% presented with antibiotic-associated diarrhea. In the analysis of antibiotic-associated diarrhea occurrence according to different geographical regions of Turkey, antibiotic-associated diarrhea episodes differed significantly (p = 0.014), particularly higher in The Eastern Anatolia and Southeastern Anatolia. Though most commonly encountered with cephalosporin use, antibiotic-associated diarrhea is not a frequent side effect. Conclusion: This study on pediatric antibiotic-associated diarrhea displayed epidemiological data and the differences geographically in our region. © 2023, The Author(s). | |
dc.identifier.DOI-ID | 10.1186/s12887-023-03939-w | |
dc.identifier.issn | 14712431 | |
dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/11703 | |
dc.language.iso | English | |
dc.publisher | BioMed Central Ltd | |
dc.rights | All Open Access; Gold Open Access | |
dc.subject | Amoxicillin-Potassium Clavulanate Combination | |
dc.subject | Anti-Bacterial Agents | |
dc.subject | Cephalosporins | |
dc.subject | Child | |
dc.subject | Diarrhea | |
dc.subject | Humans | |
dc.subject | Outpatients | |
dc.subject | Prospective Studies | |
dc.subject | amoxicillin plus clavulanic acid | |
dc.subject | cephalosporin | |
dc.subject | antiinfective agent | |
dc.subject | cephalosporin derivative | |
dc.subject | adolescent | |
dc.subject | adverse outcome | |
dc.subject | antibiotic associated diarrhea | |
dc.subject | antibiotic therapy | |
dc.subject | Article | |
dc.subject | child | |
dc.subject | clinical feature | |
dc.subject | drug safety | |
dc.subject | female | |
dc.subject | follow up | |
dc.subject | human | |
dc.subject | infant | |
dc.subject | major clinical study | |
dc.subject | male | |
dc.subject | outpatient department | |
dc.subject | prospective study | |
dc.subject | risk factor | |
dc.subject | Turkey (republic) | |
dc.subject | clinical trial | |
dc.subject | diarrhea | |
dc.subject | multicenter study | |
dc.subject | outpatient | |
dc.title | Antibiotic associated diarrhea in outpatient pediatric antibiotic therapy | |
dc.type | Article |